(RTTNews) - Friday, Profound Medical Corp. (PROF) and Telix Pharmaceuticals Limited (TLX) announced a co-education agreement to educate physicians and prostate cancer centers on the complementary roles of Telix's PSMA-PET molecular imaging technologies and Profound's MRI-guided T
Freeport-McMoRan (NYSE: FCX) and Southern Copper (NYSE: SCCO) could both benefit if copper stays tight, but for very different reasons. Freeport brings production growth and operating leverage, while Southern Copper brings enormous reserves and very low costs.
(RTTNews) - Friday, Glaukos Corporation (GKOS) announced positive topline results from a Phase 4 study evaluating iDose TR in combination with cataract surgery in patients with open-angle glaucoma (OAG) or ocular hypertension (OHT).
(RTTNews) - Avient Corp. (AVNT), a manufacturer of colorants, additives and polymers, announced Friday that its Board of Directors has appointed Mike Frank as President and Chief Executive Officer, effective immediately. Frank succeeds Ashish Khandpur, who has stepped down from h
Key PointsAMD, already past a $1 trillion market cap, needs about 70% more growth to pass Broadcom's $1.7 trillion, a target its OpenAI deal makes realistic.
Key PointsThe VanEck Semiconductor ETF's annualized 30.3% return over the past five years shows what is possible for semiconductor stocks, but Sandisk and MaxLinear can outshine the ETF over the next five years.
(RTTNews) - Friday, Teva Pharmaceuticals (TEVA) announced that the U.S. FDA has approved WELTRUZA (olanzapine) extended-release injectable suspension for adults with schizophrenia.
(RTTNews) - Friday, Eli Lilly (LLY) reported new exploratory Phase 3b data from the TOGETHER-PsO study evaluating Taltz (ixekizumab) and Zepbound (tirzepatide) in adults with psoriasis and obesity or overweight.